Charles Warden - Profile and Investment Details

Investor Profile

Charles Warden is a Venture Capital, Investor based in Burlingame, California, United States with a diverse investment portfolio that includes companies such as Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics, Aprea, CODA Biotherapeutics, Therachon, Inception IBD, Monteris Medical, Zyga Technology, Inari Medical, Century Therapeutics, Ceterix Orthopaedics, Audentes Therapeutics, Gotham Therapeutics, GenSight Biologics, Halscion, Inc., Matterhorn Biosciences, Ventus Therapeutics, Benvenue Medical, Pandion Therapeutics, T-knife, Vividion TherapeuticsNeuWave Medical, PIQUR Therapeutics, Tarveda Therapeutics, VectivBio, Akero Therapeutics, Crinetics Pharmaceuticals, Graphite Bio, Jecure Therapeutics, RayzeBio, BlueRock Therapeutics, Sebacia, Repare Therapeutics, Enterprise Therapeutics, Kinestral Technologies, Intuity Medical, Insulet, Metavention, GluMetrics, Versant Ventures, Tempest Therapeutics, Bright Peak Therapeutics, Veran Medical Technologies, Respicardia, Nouscom, Nuvaira, Quentis Therapeutics, Passage Bio, Turnstone Biologics, Oyster Point Pharmaceuticals, Chinook Therapeutics, Monte Rosa Therapeutics, Pipeline Therapeutics, Twelve, Venatorx Pharmaceuticals, Gritstone Oncology, Jnana, Ebb Therapeutics, Lava Therapeutics, ROX Medical, AcuFocus, Anokion, Ivantis, Laguna Pharmaceuticals, . Over time, Charles Warden has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Charles Warden is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Genetics, Wellness, Women Founded, Healthcare Innovation, Life Science, Biotechnology, Medical Devices, Genomics, Clinical Trials, Health Diagnostics, Medical, B2B, Therapeutics, Health Tech, Pharmaceuticals may find it worthwhile to explore potential connections with Charles Warden, as their portfolio suggests a familiarity and interest in this area.

Understanding Charles Warden’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.